Correction: Genetic basis for clinical response to CTLA-4 blockade in melanoma: To the editor

New England Journal of Medicine

Volumn 373, Issue 20, 2015, Pages 1984-

  Chan, Timothy A ^a   Wolchok, Jedd D ^a   Snyder, Alexandra ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERROR; LETTER; PRIORITY JOURNAL; ANTAGONISTS AND INHIBITORS; FEMALE; GENETICS; HUMAN; MALE; MELANOMA; SKIN TUMOR;

ANTINEOPLASTIC AGENT; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MONOCLONAL ANTIBODY;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CTLA-4 ANTIGEN; FEMALE; HUMANS; MALE; MELANOMA; SKIN NEOPLASMS;

EID: 85027289401     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1508163     Document Type: Letter

References (1)

1. Snyder A, Makarov V, Merghoub T, et al. Genetic basis for clinical response to CTLA-4 blockade in melanoma. N Engl J Med 2014;371:2189-99.